FDA Takes Issue With Boston Scientific (The Motley Fool)
Boston Scientific receives a warning letter from the FDA on a discontinued stent trial.

China points finger for product problems (CNN Money)
A top Chinese official blames importers, exporters and illegal companies for problems with certain products sent from his country to the United States, and declined Thursday to directly express government regret for the incidents.

Noticias Infobolsa / Titulares (InfoBolsa)
Guardian Technologies Announces Milestone Agreement to Acquire . Advanced Integration Technology to Accelerate Planned FDA Clinical Trials Advanced Integration Technology to Accelerate Planned FDA Clinical Trials 14/09/2007 20:01:00 Business Wire Guardian Technologies International (OTCBB:GDTI), innovators of groundbreaking medical imaging and threat detection technology with critical and ...